The Peptide Report
A transparent, physician-authored breakdown of the ipamorelin CJC-1295 prescription pathway in 2026. Learn what's legal, who qualifies, and how to avoid risky sourcing.
The 2026 landscape for ipamorelin and CJC-1295 prescriptions has changed dramatically after FDA reclassification. Here's the legal, physician-guided path forward — plus safer wellness alternatives that support energy and vitality.
